Introduction {#s1}
============

Stem cells have the remarkable ability to self-renew, divide and differentiate into diverse cell types. We are starting to realize the vast implications embryonic and adult stem cells may have for regenerative medicine. In particular, there is a great degree of interest in the development of strategies to harness the therapeutic potential of endogenous neural stem cells in the adult brain for their use in the treatment of neurological disorders. With precise and controlled manipulation, stem cells may have the capacity to replace damaged neurons, halt the progression of neurodegenerative diseases, and ultimately recover function in damaged area(s) of the brain. Since 1992, it has been know that endogenous stem and precursor cells reside in the brains of adult animals (Reynolds and Weiss, [@B57]; Richards et al., [@B58]), primarily, though by no means exclusively, in two major areas of the adult brain---the subgranular zone (SGZ) of the hippocampus, and the subventricular zone of the lateral ventricles---and have been shown to continuously generate functional new neurons throughout adulthood. Furthermore, considering recent studies demonstrating the crucial role of newborn neurons in learning and memory formation (Deng et al., [@B17]; Marin-Burgin and Schinder, [@B47]) and mood regulation (Sahay and Hen, [@B60]), the enhancement of hippocampal neurogenesis has immense potential for the treatment of age-associated cognitive decline, dementia, and mental health disorders.

Adult hippocampal neurogenesis in the SGZ is a tightly orchestrated process, involving the maintenance, activation and proliferation of the stem cells; differentiation and migration of the intermediate progenitors; and maturation of the newborn neurons (Bergami and Berninger, [@B4]; Jhaveri et al., [@B31]; Lugert et al., [@B44]). Following successful integration into the neuronal network, these neurons are able to contribute to hippocampal function, as well as sculpt the existing circuitry (Song et al., [@B65]). A host of intrinsic and extrinsic factors regulates each of these developmental stages (Zhao et al., [@B76]; Ming and Song, [@B49]; Jhaveri et al., [@B31]). To exploit the brain\'s endogenous reservoir of hippocampal neural stem cells as a potential therapeutic strategy, it is necessary to examine (1) the properties of stem cells that enable them to proliferate, and (2) the methods that can be employed to stimulate their proliferation and neuronal differentiation.

The quiescent population of stem and progenitor cells in the adult hippocampus
==============================================================================

As mentioned, a *bona fide* stem cell must have the defining characteristics of self-renewal through mitotic division, and the ability to differentiate into different cell types. On the other hand, if a cell has limited self-renewal and restricted lineage potential, it is classified as a progenitor cell (Bonaguidi et al., [@B8]). Without specific techniques to distinguish between these two cell types, stem and progenitor cells are often collectively referred to as precursor cells. Nevertheless, with our advancing understanding of the transcription factors and markers expressed during the different stages of neurogenesis (Hodge and Hevner, [@B28]; von Bohlen und Halbach, [@B73]), the introduction of constitutive reporters and inducible transgenic mouse lines (Dhaliwal and Lagace, [@B18]), and morphological criteria, successful identification of stem and progenitor cells is becoming somewhat easier.

Nevertheless, because unequivocal identification of the potential of a single precursor *in vivo* is still very difficult, characterization and enumeration of stem and progenitor cells in the hippocampus has largely arisen from *in vitro* studies utilizing the neurosphere assay (Bull and Bartlett, [@B11]; Walker et al., [@B75]; Jhaveri et al., [@B30]). When dissociated precursor cells from adult hippocampal tissue are exposed to mitogens, such as epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF), they proliferate to form a ball of cells called a neurosphere. We have found the size of a neurosphere reflects the proliferative capacity of the original precursor cell; for instance, a stem cell with great proliferative and self-renewal potential can generate a neurosphere over 250 μm in diameter, whereas a progenitor cell with limited self-replication generates a neurosphere \~50 μm in diameter (Walker et al., [@B75]; Jhaveri et al., [@B30]). Using this *in vitro* approach, our laboratory was the first to report the presence of a large and previously unidentified population of predominantly quiescent stem cells in the adult mouse hippocampus (Walker et al., [@B75]). In this study, dissociated hippocampal cells were cultured with depolarizing levels of potassium chloride (KCl), which activated a quiescent population of precursor cells to proliferate and produce a more than two-fold increase in number of neurospheres compared to control conditions. Furthermore, a small number (approximately eight per hippocampus) of very large neurospheres (\>250 μm in diameter) were obtained, which displayed the stem cell properties of self-renewal and multipotentiality. When the active and rapidly dividing precursor population (i.e., precursors that formed neurospheres under non-depolarizing conditions) were ablated with the anti-mitotic agent AraC (cytosine-b-D-arabinofuranoside), the quiescent pool of precursor cells remained intact, and responded to high KCl stimulation (Walker et al., [@B75]). Recently, we have shown that stimulation with the monoaminergic neurotransmitter, norepinephrine, directly activated another population of latent stem and precursor cells, via β3-adrenergic receptors, in the adult hippocampus, which is quite distinct from the KCl-activated population (Jhaveri et al., [@B30]). This raises the tantalizing prospect that these distinct populations may have give rise to subtly different populations of neuronal progeny. Importantly, a recent *in vivo* clonal analysis, using sparsely labeled and inducible Nestin-positive cells, confirmed the existence of a small population---of similar size to that we identified *in vitro---of quiescent* stem cells in the hippocampus that are also capable of self-renewal and multipotent differentiation (Bonaguidi et al., [@B8]).

The existence of the quiescent stem cell population in the hippocampus has important ramifications for the use of neurogenesis as a therapeutic strategy for functional recovery following brain injury and disease. Given that stem cells in the quiescent pool are usually dormant, and have a seemingly limitless capacity for proliferation, this population offers an untapped resource for the activation and augmentation of neurogenesis. Thus, the most direct and robust method of increasing the rate of neurogenesis will be to activate the quiescent stem cell pool; however, unless self-renewal in the quiescent population is precisely maintained by a number of factors, including Notch signaling (Pierfelice et al., [@B56]), its reservoir of stem cells may become depleted, leading to the premature loss of neurogenesis. Furthermore, the mechanisms regulating neuronal differentiation, survival and integration must also be well-managed to obtain successful neurogenesis.

In terms of origin, there may exist a reciprocal relationship between the quiescent and active stem cells in the hippocampus, in that they are able to give rise to one another (Suh et al., [@B67]; Lavado et al., [@B39]). Nevertheless, while these two subpopulations are kept in a delicate equilibrium by a number of factors, the precise mechanisms underlying how these pools are regulated and maintained, and the flux between their quiescent and active states, requires further characterization. Nonetheless, we believe that molecular signals may "prime" quiescent precursor cells to be able to respond to proliferative signals coming from the hippocampal niche (see Figure [1](#F1){ref-type="fig"}). Whether these signals come from newborn neurons, mature granule cells or surrounding glial cells as a result of neuronal activity is just beginning to be understood.

![**Activation of the endogenous population of quiescent stem cells in the adult hippocampus as a therapeutic strategy for neural injury and disease.** Enhancement of neurogenesis, through activation of the quiescent stem cell pool, may facilitate neuronal repair and recovery of cognitive function following aging, neuronal disorders, psychiatric conditions, and neurodegenerative diseases. For instance, neuronal activity, such as that which occurs during learning, the induction of long-term potentiation (LTP) and *in vitro* depolarization, potently activates quiescent stem cell proliferation. A different subpopulation of stem cells is activated following exposure to norepinephrine (NE), and it is thought that this population responds to NE-mediated antidepressant treatment which can alleviate clinical depression. Patterns of electrical stimulation, such as deep brain stimulation and electroconvulsive shock, which are currently used to treat many neurodegenerative and psychiatric conditions in human patients, have also been shown to promote proliferation in animal models. Newborn neurons arising from the distinct progenitor cell pools may have differential roles in the functional outcome of neurodegenerative disease and psychiatric illness. Abbreviations: NE, norepinephrine; LTP, long-term potentiation.](fncel-07-00005-g0001){#F1}

Activation of the quiescent stem cell population
================================================

The SGZ of the hippocampus is enriched with a vast number of projections arising from a number of areas throughout the brain, which modulate neuronal activity in the dentate gyrus. Neurotransmitters released from these projections have been shown to affect multiple stages of hippocampal neurogenesis (Vaidya et al., [@B70]). Furthermore, growth factors and signaling molecules that are upregulated following high-intensity neuronal activity may also modulate hippocampal neurogenesis (e.g., Balkowiec and Katz, [@B3]; Chen et al., [@B12]). For instance, environmental novelty and neuronal activity-mediated activation of noradrenergic terminals in the dentate gyrus have been shown to result in the release of norepinephrine (Harley, [@B26]; King and Williams, [@B35]; Neugebauer et al., [@B54]), which in turn has been shown to directly activate the Hes5-expressing quiescent pool of stem and precursor cells in the adult hippocampus (Jhaveri et al., [@B30]). While there is a burgeoning number of putative candidates that regulate neurogenesis, we focus here on the role of neuronal activity in the activation of the quiescent stem cell pool in the adult hippocampus.

Electrophysiological stimulation
--------------------------------

Learning-related electrophysiological stimulation of the hippocampus has been widely shown to promote precursor cell proliferation and the survival of newborn neurons in the SGZ (Bruel-Jungerman et al., [@B10]; Chun et al., [@B13]; Toda et al., [@B69]; Kitamura et al., [@B36]; Stone et al., [@B66]; Kameda et al., [@B32]). Nevertheless, the mechanisms underlying how the precursor population responds to the induction of LTP have not yet been definitively revealed. We have shown recently that activation of the precursor cell population occurs only following the successful induction of LTP in the dentate gyrus *in vivo* (Kameda et al., [@B32]). These precursors appear to be the same population that responds to KCl stimulation *in vitro*, as high KCl did not further increase the number of neurospheres in the LTP-induced hippocampal cells. The LTP-mediated activation of precursor cells, and the increase in the production of doublecortin (DCX)-positive neurons observed *in vivo*, was specific to the induction of NMDA-dependent late-LTP, as this effect was blocked by the NMDA receptor antagonist CPP \[(6)-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid\], administered shortly before the induction of LTP. Similarly, protocols that delivered low-frequency stimulation, or high-frequency stimulation that failed to induce LTP or only induced early-LTP, did not affect precursor activation or proliferation. Interestingly, the magnitude of LTP strongly correlated with the extent of precursor cell activation, suggesting a dose-dependent-like mechanism underlies this effect. While speculative, it is possible that LTP induction somehow primes hippocampal precursor cells to respond to factors that directly activate proliferation. This effect may be temporally transient, given that when the hippocampus was dissociated 4 days following the induction of LTP, no significant increase in activation of precursor cells was seen *in vitro* (Kameda et al., [@B32]). Nonetheless, these observations are the first to provide direct evidence that patterns of synaptic activity associated with learning and memory can activate latent precursor cells in the adult hippocampus, as well as increase neuron production. More studies are required to investigate the mechanism of precursor cell activation following defined patterns of physiological stimulation, considering that synaptic plasticity, learning, and neurogenesis are intimately linked.

Other patterns of electrical stimulation have also been shown promote neurogenesis. Stimulation protocols used to induce electroconvulsive seizure (ECS) robustly increase the proliferation and survival of progenitor cells in rodents (Madsen et al., [@B45]; Ito et al., [@B29]) and non-human primates (Perera et al., [@B55]). Furthermore, recent clinical advances are starting to show that deep brain stimulation (DBS) of the human brain can successfully treat many psychiatric and neurological conditions (reviewed in Cramer et al., [@B14]; Moreines et al., [@B51]; Hamani and Temel, [@B25]), and has been shown to affect neurogenesis in rodent models of disease (e.g., Khaindrava et al., [@B34]). While the link between electrical stimulation of the human brain and neurogenesis awaits investigation, a phase I clinical trial assessing the effect of DBS targeting the fornix/hypothalamus in patients experiencing mild Alzheimer\'s disease has revealed that some patients showed a slower rate of cognitive decline over a 12-month period (Laxton et al., [@B40]). Therefore, given the ability of electrical stimulation to enhance endogenous neurogenesis, and the strong links between neurogenesis in the SGZ and improvement in cognitive function (e.g., Deng et al., [@B17]; Marin-Burgin and Schinder, [@B47]), stimulating the quiescent population of stem and precursor cells to augment endogenous neurogenesis to recover or enhance cognitive function in neurodegenerative disease in an alluring prospect. Nevertheless, the identity of the latent precursor pool(s) that respond to the different patterns of electrical activity (e.g., LTP-inducing high-frequency stimulation, ECS and DBS) to generate new neurons remains to be addressed.

Hippocampal neurogenesis and aging
==================================

It is now well-established that hippocampal neurogenesis dramatically decreases with age. Aged animals show significantly less precursor and progenitor cell proliferation, neuronal differentiation and newborn neuron survival (reviewed by Lee et al., [@B41]). This is also true for the number of neurospheres that can be generated from mice as they age, which by 18 months in the hippocampus, declines by about 80% (Walker et al., [@B75]). The cause of this neurogenic decline over time is not well-understood, as many factors underlying the maintenance and regulation of neurogenesis are altered in the aged brain (Artegiani and Calegari, [@B1]; Lee et al., [@B41]). Nonetheless, given the negative impact of aging on hippocampal neurogenesis (Lee et al., [@B41]) and cognitive function (e.g., Rosenzweig and Barnes, [@B59]), stimulating the endogenous stem cell pool in the aged brain may be able to restore the memory and cognitive deficits observed in age-associated and mild cognitive impairment, and neurodegenerative diseases, such as Alzheimer\'s disease (e.g., Laxton et al., [@B40]).

To develop an effective strategy to enhance neurogenesis in the aged hippocampus, it is important to identify whether the age-related reduction in proliferation and neurogenesis results from an increase in stem cell quiescence over time (Lugert et al., [@B43]; Bonaguidi et al., [@B8]), or depletion of the stem cell pool (Encinas et al., [@B21]). A study from our laboratory has shown that the aged brain does in fact retain a population of quiescent stem cells, which have the capacity to respond to stimuli that activate proliferation *in vitro* (Walker et al., [@B75]). Indeed, physical exercise, which strongly increases stem cell proliferation and neuron production (van Praag et al., [@B71]; Kronenberg et al., [@B37]; Lugert et al., [@B43]), has been positively correlated with improved hippocampal-dependent cognitive performance in aged animals (van Praag et al., [@B72]; Marlatt et al., [@B48]). While a number of factors may underlie the neurogenic and cognitive restoration observed in aged animals following physical exercise (see Lee et al., [@B41]), a strong case has recently been made for the involvement of growth hormone in this process in the subventricular zone (SVZ) (Blackmore et al., [@B5], [@B6]). Further investigation is required to show whether growth hormone mediates exercise-induced activation of the quiescent precursor cell population in the aged hippocampus.

We have shown recently that microglia are also very important in regulating the activation of precursors in the aging animal and after exercise (Vukovic et al., [@B74]). Removal of microglia from the hippocampal population in aged animals leads to a significant increase in precursor activation, indicating the low number of active precursors may be due to the inhibitory effects of microglia, probably through the release of cytokines. Conversely, microglia removed from hippocampal cultures of young animals has no effect, but their removal following running decreases neurosphere numbers, indicating microglia play a positive role in the activation process. We have shown that the ability of microglia to increase precursor activity is due to the release of the chemokine, CX3C (also known as fractalkine) from neurons, and that levels of this ligand decrease dramatically with age (Vukovic et al., [@B74]). These results open the possibility that raising CX3C levels may increase neurogenesis in the aging animal. In addition, we have found that interferon gamma, another cytokine found normally in the hippocampus that is raised during inflammatory conditions, is also a potent inhibitor of precursor activation. Interestingly, this inhibition can be partially blocked by factors released from microglia (Li et al., [@B42]). This environment of negative and positive regulators of hippocampal precursor activation poses some challenges, especially in the aged animal, as we try to stimulate the appropriate neurogenic production in the hippocampus in a way that leads to the enhancement of function in the aged brain suffering cognitive decline, as outlined in Figure [1](#F1){ref-type="fig"}.

Hippocampal neurogenesis in mood-related disorders
==================================================

Another area of research in which hippocampal neurogenesis has received considerable attention is in the investigation of animal models of depression, and specifically, the mechanisms underlying the actions of antidepressants (reviewed by Sahay and Hen, [@B60]). Changes in hippocampal neurogenesis have now been implicated in the etiology of depression; furthermore, current antidepressant treatments are thought to target these neurogenic changes (Santarelli et al., [@B62]; David et al., [@B16]; Snyder et al., [@B64]; Surget et al., [@B68]). Given the Australian National Survey of Mental Health and Wellbeing ([@B2]) reported that about 20% of the population experience some form of mental disorder within a 12-month period, with mood-related disorders such as anxiety and depression being the most prevalent, a thorough understanding of the cellular and molecular mechanisms underlying these conditions is necessary to be able to identify novel therapeutic strategies.

Studies have shown an enhancement of hippocampal neurogenesis following chronic treatment with clinical antidepressants (Malberg et al., [@B46]; Duman, [@B19]; Perera et al., [@B55]). In particular, ECS, which initiate rapid onset of antidepressant action, have been shown to increase the proliferation of GFAP- and Sox2-positive quiescent stem cells in the SGZ (Segi-Nishida et al., [@B63]). More recently, we have shown that norepinephrine, and antidepressants that block the reuptake of norepinephrine (such as reboxetine and atomoxetine), also increase proliferation by directly activating the quiescent population of precursors in the hippocampus (Jhaveri et al., [@B30]). In fact, the neurogenesis-depression hypothesis proposes that the functional effect of antidepressant treatment is mediated by the addition of new neurons to the hippocampal network (Kempermann and Kronenberg, [@B33]). This hypothesis is supported by the strong correlation that exists between the timeline of new neuron production and the delayed onset of the beneficial effects of antidepressant medication (Nestler et al., [@B53]; Sahay and Hen, [@B60]). Importantly, the blockade of hippocampal neurogenesis has been shown to inhibit some, but not all, of the therapeutic-like effects of antidepressants in rodent models (Santarelli et al., [@B62]; David et al., [@B16]); however, no anxiety/depressive-like behavior has been observed in animals lacking neurogenesis, suggesting impairment in neurogenesis alone is not sufficient to cause mood-related disorders. To better understand the etiology of depression, a detailed understanding of the interactions between the hippocampus and other brain areas is needed, with an emphasis on the precise molecular mechanisms by which newborn neurons in the hippocampus ameliorate depression.

The hippocampus is known to play an important role in regulating stress through the hypothalamic-pituitary-adrenal (HPA) axis (Herman et al., [@B27]; Mizoguchi et al., [@B50]). While several studies have shown that chronic stress or an elevation of cortisol levels decreases neurogenesis (Gould et al., [@B24]; Murray et al., [@B52]; Lagace et al., [@B38]), two recent studies have suggested that newborn hippocampal neurons mediate the feedback inhibition of the HPA axis following stress, thereby regulating blood cortisol levels (Snyder et al., [@B64]; Surget et al., [@B68]). Surget and colleagues ([@B68]) have shown that in animals in which neurogenesis has been ablated, restraint stress leads to a longer-lasting elevation in cortisol levels compared to animals with intact neurogenesis. In addition, neurogenesis-ablated mice show increased food avoidance in a novel environment, indicating higher levels of anxiety. Importantly, Surget and colleagues ([@B68]) have shown that fluoxetine treatment, in the absence of ongoing neurogenesis, fails to restore HPA axis activity and function in neurogenesis-ablated animals subjected to unpredictable chronic stress.

Taken together, it appears that functional hippocampal neurogenesis plays an important role in preventing the onset of mood-related disorders following chronic stress, and importantly, acts as a substrate for the therapeutic action of antidepressants. Enhancing the production of newborn neurons by harnessing the potential of endogenous precursor populations may therefore be an extremely useful therapeutic approach (see Figure [1](#F1){ref-type="fig"}). Given that at least two large latent precursor populations have been uncovered so far in the hippocampus (Walker et al., [@B75]; Jhaveri et al., [@B30]), driving neuronal production by enhancing the proliferative activity could indeed boost hippocampal neurogenesis. While the monoaminergic family of drugs remain the front line choice for the treatment of mood disorders, their ineffectiveness and distressing side effects warrants the discovery of new antidepressant treatments (Ellis, [@B20]). More effective, rapid-acting and long-lasting antidepressants may emerge from undertaking a detailed molecular characterization of these latent precursor pools, as well their neuronal progeny, which may lead to the identification of novel targets for drug development (Jhaveri et al., [@B31]). Finally, enhancing neuronal production may also prove beneficial for neurodegenerative diseases that involve significant cellular and functional loss in the hippocampus.

Conclusions {#s2}
===========

Resident populations of endogenous stem and progenitor cells drive the production of new neurons in the adult hippocampus. These precursor pools are carefully regulated and precisely maintained, such that upon pathological insult or homeostatic perturbations, proliferation can be rapidly enhanced to replace neurons lost due to damage or dysfunction. Nevertheless, enhancing proliferation alone is often not enough to generate sufficient numbers of new neurons and restore normal function. As such, various methods of further activating and amplifying stem and progenitor cells in the hippocampus have provided some positive results for the recovery of hippocampal-dependent behavioral functions in animal models.

While we have discussed the stimulation of endogenous neural stem cells in a number of disease states in rodent models, effective therapies for human application must be tailored to the endogenous microenvironment of the human neurogenic niche. Currently, there are limited studies providing evidence for ongoing hippocampal neurogenesis in the adult human brain (Eriksson et al., [@B23]; Blumcke et al., [@B7]; Sanai et al., [@B61]); furthermore, the cell cycle length in primates appears to be substantially longer than in rodents, indicating a much slower rate of proliferation and precursor cell turnover (Breunig et al., [@B9]; Curtis et al., [@B15]). Additional research is therefore required to examine the extent of adult neurogenesis in the human brain, for instance, using post-mortem brain tissue from age-matched controls, as well as patients suffering from mood and neurological disorders. Given that post-mortem brain tissue can only provide a temporal snapshot of neurogenesis, advances in live imaging techniques that can track cell proliferation in the human hippocampus at high resolution will open an exciting avenue for future investigation. In addition, the development of sophisticated drug delivery technology is needed to specifically target and activate proliferation of the endogenous populations of stem cells, and to facilitate the differentiation, migration, integration, and survival of newborn neurons. Nevertheless, a detailed understanding of the fundamental mechanisms regulating neurogenesis in animal models will be crucial in order to utilize the endogenous stem cell populations as a therapeutic approach in patients suffering from brain injury and disease.
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